APM Aptorum Earnings per share increase in current year
Can robotic molecule screening systems increase the capitalization of Aptorum Group Limited? The relative annual growth in net income per share provides the answer, where the value of 0.00 expresses the metric level. This trend captures the commercialization of the diagnostic IT platform and the success of small molecules. The business is currently optimizing its drug portfolio for rare pathologies in an effort to attract major strategic partners.
Analytical breakdowns and data insights for company aptorumgroup.com (APM)
- stock value and consensus price forecast:
- market capitalization data:
- business book valuation details:
- debt burden and liquidity indicators:
- earnings and market multiples details:
APM - Net Income|Expected Net Income Aptorum Group Limited|APM - P/E Multiple|Forward Price to Earnings Multiple Aptorum Group|APM - Price/Earnings to Growth Ratio|Business Value to Operating Income Before Depreciation APM|APM - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months Aptorum Group|APM - Net earnings per share for the last 12 months|Quarterly EPS earnings growth aptorumgroup.com|APM - Earnings per share growth in current year|Net earnings per share change forecast for next year Aptorum Group Limited
Basic company analysis:Aptorum (APM)
Aptorum Group Limited is developing innovative therapies amidst stringent geopolitical restrictions. The dynamics of these processes directly impact the estimated annual net profit growth per share in percentage terms. This metric measures the rate of change in EPS, identifying the true sector leader through peer comparison. The indicator highlights valuation vulnerabilities when sanction barriers hinder research. Analyzing this figure warns against overpaying for the asset prior to a potential drawdown.
Key competitors
Earnings per share growth rate in current year Haleon PLC (HLN)|Earnings per share growth in current year Kenvue Corp|VRNA: Earnings per share increase in current year|Earnings growth in current year MENS|Earnings growth in current year ligand.com (LGND)|Earnings per share growth in current year Amneal AMRX|PRGO (Perrigo Company PLC) - Earnings per share trend in current year|ALVO: Net earnings per share growth this year|Liquidia Inc. - Net earnings per one share growth for the current year|Galapagos NV (GLPG) - Earnings per share growth in current year|Earnings per share growth rate in current year anipharmaceuticals.com (ANIP)|Earnings per share growth in current year MannKind|AMPH: Earnings per share increase in current year|Net earnings per share growth this year PCRX (Pacira)|Earnings growth in current year ARS Corp (SPRY)|Earnings per share growth in current year Theravance Biopharma TBPH|AQST - Net earnings per share growth this year|SCPH: Net earnings per share growth this year|Earnings per share increase in current year TECX (Tectonic Therapeutic, Inc.)|TNXP: Earnings growth in current year|Net earnings per share change in current year China SXT Pharmaceuticals, Inc. SXTC|Earnings per share growth in current year Eupraxia Pharmaceuticals, Inc.|BHST: Earnings per share increase in current year|Earnings per share growth in current year eXoZymes (EXOZ)|ORMP - Earnings per share growth rate in current year|Entera Bio - Net earnings per share growth this year|Earnings growth in current year MindWalk Therapeutics HYFT|ABVC - Earnings per share growth in current year|Earnings per share trend in current year CPIX|QNTM (Quantum BioPharma) - Net earnings per share growth this year|FibroGen Inc - Earnings per share increase in current year|Earnings per share growth in current year Telomir Pharma|Earnings per share growth in current year RANI|Earnings growth in current year SNYR|Expected net earnings per share growth this year rallybio.com|Earnings per share growth in current year Lexaria Bioscience Corp. LEXX|PULM - Net earnings per share growth this year|Pheton - Earnings growth in current year|Expected net earnings per share growth this year Lyra Therapeutics Inc LYRA|IBO (Impact BioMedical) - Net earnings per share growth this year|TNFA: Net earnings per one share growth for the current year|YCBD (cbdMD Inc.) - Earnings growth in current year|Earnings per share growth rate in current year PainReform Ltd PRFX|Earnings growth in current year CYTO|Lipella Pharma - Earnings per share growth this year|Earnings growth in current year OPTN (OptiNose, Inc.)|Earnings growth in current year pieris.com PIRS|PROC - Earnings per share growth in current year|Earnings per share trend in current year PTPI|Qilian International Holding Group Limited (QLI) - Earnings per share growth in current year|Net earnings per share growth this year ACELYRIN Inc.|Earnings per share growth in current year TFF Pharmaceuticals
